Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 316

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Global challenges and policy solutions in breast cancer control

Open access
Trapani, Dario, Ginsburg, Ophira, Fadelu, Temidayo, Lin, Nancy U., Hassett, Michael, Ilbawi, Andre M., Anderson, Benjamin O., Curigliano, Giuseppe·2022·Cancer Treatment Reviews

Abstract

Breast cancer is the leading cause of cancer morbidity, disability and mortality in women, worldwide. Overall, in 2020, it was the most diagnosed malignancy. Differences in breast cancer mortality have been historically evidenced, as a result of disparities in access to diagnosis, treatment and palliative care. Epidemiologic trends in the last decades display three main patterns of breast cancer mortality: some high-income countries report continuous substantial improvements exceeding 2% annual mortality reduction; however, many low- and middle-income countries (LMICs) have stagnant or even increasing mortality rates. Population-based studies show that investing in breast cancer control, based on a primary health care approach, and expanding the cancer treatment capacity can portend population health benefits, with positive changes of the epidemiological adverse trajectories. Framed as part of the political commitment to the Sustainable Development Goals Agenda, World Health Organization (WHO) has recently launched a global initiative to tackle disparities in breast cancer mortality. The WHO-led Global Breast Cancer Initiative (GBCI) is framed across 3 pillars, to address key determinants of the cancer-related outcomes: health promotion and early detection, timely access to diagnosis and treatment, comprehensive breast cancer treatment, palliative and survivorship care. GBCI is a systematized approach, with the goal to (i) increase the fraction of newly diagnosed invasive cancers being stage 1 or 2 at diagnosis (60% or more), (ii) ensure diagnostic work-up to be completed within 60 days from the first connection with the primary healthcare providers to avoid delays in diagnosis and treatment and (iii) assure 80% or more women with breast cancer to undergo and complete multimodal treatments. GBCI will pursue a comprehensive and multisectoral approach, to deliver population health, social and economic benefits, ultimately intended as an entry point for health system strengthening and for the broader cancer control.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ctrv.2022.102339

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 50 references

Research works printed but not linked: 7

  1. Mandelblatt, 2011, Modeling the impact of population screening on breast cancer mortality in the United States, The Breast, 20, S75, 10.1016/S0960-9776(11)70299-5 · doi:10.1016/s0960-9776(11)70299-5
  2. Qu, 2020, Interventions Addressing Barriers to Delayed Cancer Diagnosis in Low- and Middle-Income Countries: A Systematic Review, Oncologist, 25, e1382, 10.1634/theoncologist.2019-0804 · doi:10.1634/theoncologist.2019-0804
  3. Trapani, 2021, The global landscape of availability, accessibility and affordability of essential diagnostics and therapeutics for the management of HER2-positive breast cancer: The ONCOLLEGE-001 survey, J Cancer Policy, 28, 100285, 10.1016/j.jcpo.2021.100285 · doi:10.1016/j.jcpo.2021.100285
  4. Trapani, 2020, Breast Cancer: Reimbursement Policies and Adoption of New Therapeutic Agents by National Health Systems, Breast Care, 14, 373, 10.1159/000502637 · doi:10.1159/000502637
  5. Trapani, 2021, The global landscape of drug development of trastuzumab biosimilars, J Cancer Policy, 28, 100273, 10.1016/j.jcpo.2021.100273 · doi:10.1016/j.jcpo.2021.100273
  6. Global Governance Project. Health – A Political Choice: Solidary, Science and Solutions; 2021. Available at: https://edition.pagesuite-professional.co.uk/html5/reader/production/default.aspx?pubname=&edid=6928479a-6546-41b2-a749-c6bec78a3f08.
  7. Yamauchi H, Kitano A, Fukuda T. Socioeconomic impact of breast cancer survivors. Meeting of the American Society of Clinical Oncology 2014. #e20611. DOI: 10.1200/jco.2014.32.15_suppl.e20611 Journal of Clinical Oncology 32, no. 15_suppl. · doi:10.1200/jco.2014.32.15_suppl.e20611

Cited by

See all 316

Metadata

Authors
Trapani, D., Ginsburg, O., Fadelu, T., Lin, N. U., Hassett, M., Ilbawi, A. M., Anderson, B. O., & Curigliano, G.
Venue
Cancer Treatment Reviews
Publisher
Elsevier BV
Published
2022-03
Volume
104
Pages
102339
ISSN
0305-7372 (ISSN-L)
OpenAlex
W4206765651
Cited by
316
References
50
FWCI
23.56
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Global challenges and policy solutions in breast cancer control. https://app.cochat.ai/papers/10.1016/j.ctrv.2022.102339
The paper
Trapani, D., Ginsburg, O., Fadelu, T., Lin, N. U., Hassett, M., Ilbawi, A. M., Anderson, B. O., & Curigliano, G. (2022). Global challenges and policy solutions in breast cancer control. Cancer Treatment Reviews. https://doi.org/10.1016/j.ctrv.2022.102339

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.